FEATURED ARTICLE Branded Generics Promise Profits for Drugmakers, Peace of Mind for Patients Developing nations offer welcoming and growing markets as Abbott focuses exclusively on reformulating and marketing off-patent medications…
The post DrugPatent…
Drugs contain ingredients with therapeutic activity, so-called “active ingredients” as well as inactive ingredients. These inactive ingredients, called excipients, are included in oral products for various reasons, such as to…
The post 2 Strategies to …
2 Strategies to Grow Your Excipient Business by Tracking Drug Patents Read Post »
SPIRIVA (tiotropium bromide) Boehringer ingelheim Patent: 6,777,423 Expiration: Mar 24, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The po…
Drug Patent Expirations for the Week of March 20, 2022 Read Post »
This chart shows the drugs with the most patents in Greece. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Greece? …
Which pharmaceutical drugs have the most drug patents in Greece? Read Post »
This chart shows the drugs with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Bulgar…
Which pharmaceutical drugs have the most drug patents in Bulgaria? Read Post »
This chart shows the drugs with the most patents in Argentina. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Argen…
Which pharmaceutical drugs have the most drug patents in Argentina? Read Post »
Annual Drug Patent Expirations for OXLUMO Oxlumo is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are eleven patents protecting this drug. This drug…
The post New patent for Alnylam Pharms drug OXLUMO appeared first on DrugPat…
Annual Drug Patent Expirations for DEFINITY Definity is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Lantheus Medcl drug DEFINITY appeared first on Drug…
Annual Drug Patent Expirations for DEFINITY+RT Definity Rt is a drug marketed by Lantheus Medcl and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Lantheus Medcl drug DEFINITY RT appeared first on Dru…
Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs. This is one of the longest exclusivity terms provided by…
The post Pharmaceutical companies with the most ‘New Chemic…
Pharmaceutical companies with the most ‘New Chemical Entity’ drugs Read Post »
Get new actionable insights and updates from BiotechBlog
